⚠Due to planned maintenance you will experience short (<30 min) downtime between 08:00 - 08:30 CET.
Operational information
This data is publicly available. Parent page : ION-8362
Operational data for Thai National Stem Cell Donor Registry - ION-8362 | |
---|---|
Organisation Overview | |
The information has been reviewed in year : | 2023 |
Issuing organisation Number (ION) | ION-8362 The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA. |
Time zone | Asia/Bangkok (GMT+07:00) The timezone in which this organisation operates. |
Business hours | 8:30 AM - 4:30 PM The daily hours in which this organisation operates. |
Work schedule | Monday - Friday The normal work week in which this organisation operates. |
Organisation closures | TSCDR closes on major public holidays as gazetted by Office of the Prime Minister of Thailand. For all organisation closures, please see the WMDA Calendar. |
Donor ID example | Donor ID 902418060 and GRID 8362 0000 9024 1806 026 ID to be expected on paperwork, samples, and products. |
Preliminary Search | |
Requires preliminary search request form | No If yes, form required can be found on the Documents Page. |
Extended Typing | |
Typing options available for request | IR for HLA*-A, B, C, DRB1, DQB1, DRB3/4/5 HR for HLA*-A, B, C, DRB1, DQB1, DPB1, DRB3/4/5, DQA1, DPA1 Please note special requirements listed |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
Number of days donor is reserved for a patient after a request | 30 days |
Verification Typing | |
Maximum blood volume allowed | 30 mL sample type can be requested are EDTA, CPDA and no anticoagulant |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
IDM testing performed at verification | Yes |
Number of days donor is reserved for a patient after a request | 90 days |
Sibling Typing | |
Registry is willing to arrange sibling typings | Yes |
If yes, procedure to apply for sibling typings | Please send email request to tscdr.coordinators@redcross.or.th and do the following; 1) TSCDR accept the request through international registry only. 2) Sibling donor must be informed basic information about blood collection or stem cell collection process before contact to TSCDR staff. 3) Sibling donor has to pay for travel by themselves. 4) For all cost, TSCDR will send invoice to the international registry. |
Workup Request | |
Product dosage limit | In PBSC collection, if donor has adverse reaction and Dose CD34 ≥ 4 x 10^6/kg, do not allow collect in the next day. Number of donor cells allowed based on recipient weight. |
Requires patient to meet certain standards in order to proceed with collection | Yes Organisation may or may not allow donor collections for some patients. |
Patient physician must report the following in order to proceed with collection | TSCDR accepts request for donor from countries which are EMIDIS and MatchPoint member via MatchPoint system. National registry which is not EMIDIS and MatchPoint member needs to send a request through email. Individual transplant center which is not a member of registry needs to comply with TSCDR minimum requirements for stem cell transplant center/hospital in order to request for Thai donor. Must provide additional information to organisation. |
Requires organisation specific work up forms | No If yes, form(s) required can be found on the Documents Page. |
Workup IDM completed 30 days prior to collection | Yes Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed. |
Medical Health Questionnaire example available | Not applicable If yes, the example can be found on the Documents Page. |
Post-Transplant | |
Subsequent donation policy | Yes |
Anonymous contact allowed | Yes |
Direct contact allowed | No |
Gift exchange allowed | Yes, not of significant value and anonymous. |
Cord blood contact allowed | No |
IDM
IDM | Tested | Method | Days between test and sampling/workup |
---|---|---|---|
ALT/ASTALT/AST ratio, De-Ritis-Quotient | On request | ||
ChagasChagas, T. cruzi | On request | Trypanosoma cruzi Antibody (Quest diagnostic), Immunoassay | |
CMV IgGCytomegalovirus (CMV) Antibody testing IgG | Yes | CMIA | |
CMV IgMCytomegalovirus (CMV) Antibody testing IgM | Yes | CMIA | |
CMV TotalCytomegalovirus Total | No | ||
EBV IgGEpstein-Barr Virus Antibody testing IgG | On request | EIA | |
EBV IgMEpstein-Barr Virus Antibody testing IgM | On request | ELISA | |
HAV (NAT)Anti-hepatitis A virus nucleic acid testing | On request | RT-PCR | |
HBV (NAT)Hepatitis B nucleic acid testing | Yes | Individual NAT | |
HBc AbHepatitis B core antibody testing | Yes | CMIA | |
HBs AgHepatitis B Surface antigen testing | Yes | CMIA | |
HCV (NAT)Hepatitis C nucleic acid testing | Yes | Individual NAT | |
HCV AbHepatitis C antibody testing | Yes | CMIA | |
HEV (NAT)Hepatitis E Virus nucleic acid testing | On request | RT-PCR | |
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing | Yes | Individual NAT | |
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing | Yes | CMIA with HIV Ag/Ab combination | |
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing | Yes | CMIA with HIV Ag/Ab combination | |
HIV p24Human Immunodeficiency Virus p24 antigen testing | Yes | CMIA with HIV Ag/Ab combination | |
HTLV-IHuman T-Lymphotropic Virus type I testing | Yes | Anti-HTLVI/II, CMIA | |
HTLV-IIHuman T-Lymphotropic Virus type II testing | Yes | Anti-HTLVI/II, CMIA | |
MalariaMalaria | On request | Malaria Ag screening, immunochromatography, Remark: On request at VT and mandatory testing at WU. | |
HSVHerpes Simplex Virus | On request | HSV IgG and HSV IgM by ELISA, Multiplex Real-time PCR | |
STSSerological tests for syphilis | Yes | CMIA | |
STS FTA-ABSSerological test for syphilis | On request | IFA | |
ToxoplasmosisToxoplasmosis | On request | CMIA, IFA, Realtime PCR | |
VZVVaricella Zoster Virus | On request | ELFA, EIA, IFA, Real-time PCR, Immunofluorescent assay | |
WNV-NATWest Nile Virus nucleic acid testing | On request | Real-time PCR | |
Other tests performed | No |
Regulatory information
The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
General | |
---|---|
The information has been reviewed in year : | 2023 |
Organisation name: | Thai National Stem Cell Donor Registry (TSCDR) |
Organisation ION: | ION-8362 |
Country: | Thailand |
Year the registry started operations: | 2002 |
Products | comment | |
---|---|---|
Do you provide HPC, Marrow? | yes | |
Do you provide HPC, Apheresis? | yes | |
Do you provide HPC, Cord Blood? | yes | |
Do you provide MNC, Apheresis? | yes | |
Do you provide NC, Whole Blood? | yes |
Product quantity | ||
---|---|---|
Data valid for year | 2022 | |
Number of products | National | International |
HPC, Marrow products: | 2 | 1 |
HPC, Apheresis: | 44 | 29 |
HPC, Cord: | 0 | 0 |
License | |
---|---|
Organisation is licensed/accredited by the Competent Authority: | yes |
Comment: | |
Name of Competent Authority: | WMDA Qualified and ISO9001:2015 |
Date of last inspection: | 1) WMDA 2018-03-27 2) ISO9001:2015 date of issue 2023-03-22/valid until 2026-03-21 |
Link to website of Competent Authority: | http://masci.or.th/ |
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? | yes |
Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited? | WMDA Qualified |
The registry is accredited by any other organisation: | no |
If yes, by which organisation? |
Affiliation | |
---|---|
The registry works with the following number of affiliated donor centres: | 1 (TSCDR is also donor centre) |
The registry audits its donor centres: | We have an internal audit once per year |
The registry works with the following numer of affiliated collection centres: | 4 |
Ther registry audits its collection centres: | Every 4 years |
The registry works with the following number of affiliated Cord Blood Banks: | 1 (TSCDR have cord blood bank located at National Blood Centre) |
The registry audits its Cord Blood Banks: | We have an internal audit once per year |
The registry works with the following number of affiliated transplant centres: | 6 |
The registry audits its transplant centres: | 3 years for the first renewal, and every 5 years for the next renewal. |
The registry works with the following number of affiliated IDM Testing Laboratories: | 1 (TSCDR is also IDM testing Laboratory) |
The registry audits its IDM Testing Laboratories: | We have an internal audit once per year |
The registry works with the following number of affiliated HLA/other DNA markers testing laboratories: | 1 (TSCDR is also HLA Laboratory) |
The registry audits its HLA/other DNA markers testing laboratories: | We have an internal audit once per year |
The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: | yes |
The Cord Blood Banks are FACT-NetCord accredited: | no |
If yes, the following Cord Blood Bank(s) are accredited: | |
The registry is able to provide a copy of all the certificates: | yes |
Affiliated centres comply with WMDA Standards and applicable national regulations: | yes |
The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: | yes |
If yes, what are these requirements? | Transplant center and collection center must be audits by TSCDR compliance with WMDA guideline. |
Donor policy | |
---|---|
All donors are unpaid volunteers: | yes |
All donors are informed about donation process and associated risks: | yes |
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: | yes |
The registry has systems in place to protect and control access to donor/patient records: | yes |
The registry maintains donor anonymity: | yes |
The registry has detailed donor evaluation and exclusion criteria in place: | yes |
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: | yes |
Testing | |
---|---|
The physical and medical exam at donor workup is performed by a medical doctor: | yes |
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: | yes |
HLA typing for patient specific request is performed in an appropriately accredited laboratory: | yes |
Sterility testing is performed on the adult donor product: | yes |
Sterility testing is performed on the cord blood product: | yes |
Screening questionnaire to exclude communicable disease: | yes |
Screening questionnaire to exclude donors with 'high risk' lifestyles: | yes |
Donor reliability identified by a medical doctor: | yes |
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC : | yes |
Customs regulations | |
---|---|
Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify: | No |
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify: | No |
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify: | No |
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify: | No |
Reporting of Serious Adverse Events | |
---|---|
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in: | |
- Mandatory National Reporting Scheme | no |
- Voluntary National Reporting Scheme | yes |
- WMDA SEAR/SPEAR Reporting Scheme | yes |
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: | yes |
Quality management | |
---|---|
The registry does maintain Standard Operating Procedures for your work: | yes |
The registry would be willing to provide these to WMDA or another registry upon request: | yes |
The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: | yes |
Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained: | More than 30 years |